Clinical Trial Update: Evaluation of a New Cardiac Biomarker Assay [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a new Abbott Diagnostics cardiac biomarker assay in patients with acute coronary syndrome and acute myocardial infarction has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Abbott cardiac biomarker assay

Snippet

Sponsor: Abbott Diagnostics Division | Conditions: Acute Coronary Syndrome, Acute Myocardial Infarction | Phase 3 | Status: COMPLETED | Results posted: 2015-03-17